During the past decade, Beatrix Children's Hospital, University Medical Center Groningen conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beatrix Children's Hospital, University Medical Center Groningen" #1 sponsor was "Origin Biosciences" with 3 trials, followed by "Actelion" with 2 trials sponsored, "Aimmune Therapeutics, Inc." with 2 trials sponsored, "PTC Therapeutics" with 2 trials sponsored and "University Medical Center Groningen" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beatrix Children's Hospital, University Medical Center Groningen" #1 collaborator was "Amsterdam UMC, location VUmc" with 1 trials as a collaborator, "Erasmus Medical Center" with 1 trials as a collaborator, "Maastricht University Medical Center" with 1 trials as a collaborator, "Marien Hospital Wesel" with 1 trials as a collaborator and "Numico Research Wageningen, the Netherlands" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Beatrix Children's Hospital, University Medical Center Groningen" are "Molybdenum Cofactor Deficiency" (2 trials), "Peanut Allergy" (2 trials), "Phenylketonuria" (2 trials), "Pulmonary Arterial Hypertension" (2 trials) and "Arthritis, Juvenile Rheumatoid" (1 trials). Many other conditions were trialed in "Beatrix Children's Hospital, University Medical Center Groningen" in a lesser frequency.

Most popular intervention types in "Beatrix Children's Hospital, University Medical Center Groningen" are "Drug" (9 trials), "Biological" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "AR101" (2 trials), "Bosentan" (2 trials), "PTC923" (2 trials), "Placebo" (2 trials) and "Burosumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Beatrix Children's Hospital, University Medical Center Groningen" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Beatrix Children's Hospital, University Medical Center Groningen". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in Beatrix Children's Hospital, University Medical Center Groningen, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Beatrix Children's Hospital, University Medical Center Groningen, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".